precancerous lesion of the uterine cervix
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pregnant patients aged 20 to 45 years old; 2. The patients have been diagnosed with ASC-US?ASC-H?CIN?AGC and or HPV 16/18 positive, who need colposcopy for cervical tissue biopsy; 3. The subjects voluntarily joined this study, signed an informed consent form, had good compliance, and cooperated with follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients who have been previously diagnosed with cervical HSIL and have undergone standardized surgical treatment; 2. History of malignant tumors in the reproductive system; 3. Patients who are unwilling to undergo follow-up 6 months after parturition; 4. Refusal to sign informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rates of cervical intraepithelial neoplasia 3 (CIN3) or more severe lesions in patients;Rate of regression of cervical lesions in patients; | — |
Countries
China
Contacts
Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine